Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-7 of 7 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2005Once-monthly administration of darbepoetin alfa for the treatment of patients with chronic heart failure and anemia - A pharmacokinetic and pharmacodynamic investigationCleland, J.; Sullivan, J.; Ball, S.; Horowitz, J.; Agoram, B.; Rosser, D.; Yates, W.; Tin, L.; Fuentealba, P.; Burton, P.
2003Specialist nurse management programmes - Economic benefits in the management of heart failureStewart, S.; Horowitz, J.
2011Effects of aging, renal dysfunction, left ventricular systolic impairment, and weight on steady state pharmacokinetics of perhexilineLing, L.; Chik, W.; Averbuj, P.; Pati, P.; Sverdlov, A.; Ngo, D.; Morris, R.; Sallustio, B.; Horowitz, J.
2013Impact of chronic congestive heart failure on pharmacokinetics and vasomotor effects of infused nitriteMaher, A.; Arif, S.; Madhani, M.; Abozguia, K.; Ahmed, I.; Fernandez, B.; Feelisch, M.; O'Sullivan, A.; Christopoulos, A.; Sverdlov, A.; Ngo, D.; Dautov, R.; James, P.; Horowitz, J.; Frennaux, M.
2000Low doses vs. high doses of the angiotensin converting-enzyme inhibitor lisinopril in chronic heart failure: a cost-effectiveness analysis based on the Assessment of Treatment with Lisinopril and Survival (ATLAS) StudySculpher, M.; Poole, L.; Cleland, J.; Drummond, M.; Armstrong, P.; Horowitz, J.; Massie, B.; Poole-Wilson, P.; Ryden, L.
2001Cardiovascular critical event pathways for the progression of heart failure; A report from the ATLAS studyCleland, J.; Thygesen, K.; Uretsky, B.; Armstrong, P.; Horowitz, J.; Massie, B.; Packer, M.; Poole-Wilson, P.; Ryden, L.
2006Extending the horizon in chronic heart failure: Effects of multidisciplinary, home-based intervention relative to usual careInglis, S.; Pearson, S.; Treen, S.; Gallasch, T.; Horowitz, J.; Stewart, S.